30 Posts Not To Miss From ASCO 2026 Day 3
Jun 01, 2026
View online
30 Posts Not To Miss From ASCO 2026 Day 3
RASolute 302 Trial at ASCO 2026 Plennary Session: Daraxonrasib Improves Survival Versus Chemotherapy in Previously Treated Metastatic PDAC
SARC041 Trail at ASCO 2026 Plenary Session: Abemaciclib in Advanced Dedifferentiated Liposarcoma
PROTEUS Trial at ASCO 2026 Plenary Session: Perioperative Apalutamide Plus ADT in High-Risk Localized or Locally Advanced Prostate Cancer
HARMONi-6 Trial at ASCO Plenary 2026: Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Squamous Non-Small Cell Lung Cancer
Talha Badar: Key Hematologic Malignancy Posters from ASCO26
LIBRETTO-432 Trial at ASCO 2026 Plenary Session: Adjuvant Selpercatinib in RET Fusion-Positive NSCLC
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA
ACOG Foundation 2026 Request for Grant Proposals
Clinical Trial Statistics for Non-Statisticians Workshop
64th Annual Conference of the Particle Therapy Cooperative Group (PTCOG 64)
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
